A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus Carriers
Status:
Completed
Trial end date:
1999-12-01
Target enrollment:
Participant gender:
Summary
* AIMS OF THE STUDY
1. To test if steroid-free chemotherapeutic regimens decrease the risk of HBV reactivation
and hepatitis development in HBsAg (+) carriers.
2. To compare the efficacy of steroid-free chemotherapeutic regimens with that of
steroid-containing regimens in terms of lymphoma control.
3. To study the change of activity of HBV and other hepatotropic viruses during the course
of chemotherapy.